Is a complete CSE/HEAL research report available?

No complete published report is available for cse/HEAL (CSE/HEAL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/HEAL (CSE/HEAL)

Canadian Securities Exchange: CSE/HEAL · CAD

CA$0.07

-0.00 (-7.1%)· Recorded snapshot

Market cap	4.1M
Revenue (ttm)	465.7K
Net income (ttm)	-1.7M
EPS (ttm)	-CA$0.04
Shares out	62.5M
Volume	190,750
Beta	-0.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 465.7K
Net income (ttm): -1.7M
EPS (ttm): -CA$0.04
Market cap: 4.1M

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 3.6M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA76134J2065
Last earnings date	2025-11-27
Last refreshed	2026-10-29
Last stock split date	2025-01-24
Last stock split type	Reverse
Market cap	CAD 4.1M
Next earnings date	2026-11-27
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	cse/HEAL
Website	https://www.restartlife.co

Metric

Value

Amount currency

CAD

Country

Canada

Country code

Earnings date

2026-11-27

Enterprise value

CAD 3.6M

Exchange

Canadian Securities Exchange

Financial currency

CAD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

2004

Industry

Biotechnology

Is primary listing

Yes

ISIN number

CA76134J2065

Last earnings date

2025-11-27

Last refreshed

2026-10-29

Last stock split date

2025-01-24

Last stock split type

Reverse

Market cap

CAD 4.1M

Next earnings date

2026-11-27

Price

CAD 0.07

Price currency

CAD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-29

Symbol

cse/HEAL

Website

https://www.restartlife.co

Metric	Value
Earnings yield	-54.69%
EV/Sales	8.51x
FCF / EV yield	-24.76%
FCF yield	-22.42%
P/B ratio	3.3x
P/S ratio	9.4x
Price / tangible book value	8.02x

Metric

Value

Earnings yield

-54.69%

EV/Sales

8.51x

FCF / EV yield

-24.76%

FCF yield

-22.42%

P/B ratio

3.3x

P/S ratio

9.4x

Price / tangible book value

8.02x

Metric	Value
Gross margin	41.36%
Operating margin	-376.1%
Pretax margin	-367.41%
ROA	-100.38%
ROA (5Y)	-236.23%
ROCE	-131.49%
ROE	-246.66%
ROIC	-126.14%
SBC / revenue	253.73%

Metric

Value

Gross margin

41.36%

Operating margin

-376.1%

Pretax margin

-367.41%

ROA

-100.38%

ROA (5Y)

-236.23%

ROCE

-131.49%

ROE

-246.66%

ROIC

-126.14%

SBC / revenue

253.73%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth (QoQ)	146.12%
Revenue growth 5Y	177.25%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth (QoQ)

146.12%

Revenue growth 5Y

177.25%

Revenue growth years

Metric	Value
Depreciation and amortization	CAD 3,612
EBIT	CAD -1.8M
EBITDA	CAD -1.7M
EPS	CAD -0.04
FCF per share	CAD -0.02
Financing cash flow	CAD 2.4M
Free cash flow	CAD -980,851
Free cash flow minus SBC	CAD -2.2M
Gross profit	CAD 192,636
Investing cash flow	CAD -944,116
Net borrowing	CAD 236,064
Net cash flow	CAD 471,273
Net income	CAD -1.7M
Operating cash flow minus SBC	CAD -2.2M
Operating income	CAD -1.8M
Revenue	CAD 465,715
Stock-based compensation	CAD 1.2M

Metric

Value

Depreciation and amortization

CAD 3,612

EBIT

CAD -1.8M

EBITDA

CAD -1.7M

EPS

CAD -0.04

FCF per share

CAD -0.02

Financing cash flow

CAD 2.4M

Free cash flow

CAD -980,851

Free cash flow minus SBC

CAD -2.2M

Gross profit

CAD 192,636

Investing cash flow

CAD -944,116

Net borrowing

CAD 236,064

Net cash flow

CAD 471,273

Net income

CAD -1.7M

Operating cash flow minus SBC

CAD -2.2M

Operating income

CAD -1.8M

Revenue

CAD 465,715

Stock-based compensation

CAD 1.2M

Metric	Value
Altman Z-Score	-42.78
Book value per share	CAD 0.02
Debt / equity	0.26
Goodwill	CAD 779,294
Interest coverage	-85.48
Long-term assets	CAD 845,530
Long-term liabilities	CAD 7,297
Net cash (debt)	CAD 414,018
Net cash / market cap	9.46%
Net cash growth	57.79%
Net debt / equity	-0.31
Piotroski F-Score	2
Property, plant and equipment	CAD 66,236
Shareholders' equity	CAD 1.3M
Tangible book value	CAD 545,454
Tangible book value per share	CAD 0.01
Total assets	CAD 1.9M
Total cash	CAD 762,363
Total debt	CAD 348,345
Total liabilities	CAD 578,899
WACC	0.29%

Metric

Value

Altman Z-Score

-42.78

Book value per share

CAD 0.02

Debt / equity

0.26

Goodwill

CAD 779,294

Interest coverage

-85.48

Long-term assets

CAD 845,530

Long-term liabilities

CAD 7,297

Net cash (debt)

CAD 414,018

Net cash / market cap

9.46%

Net cash growth

57.79%

Net debt / equity

-0.31

Piotroski F-Score

Property, plant and equipment

CAD 66,236

Shareholders' equity

CAD 1.3M

Tangible book value

CAD 545,454

Tangible book value per share

CAD 0.01

Total assets

CAD 1.9M

Total cash

CAD 762,363

Total debt

CAD 348,345

Total liabilities

CAD 578,899

WACC

0.29%

Metric	Value
Asset turnover	0.43
Current assets	CAD 1.1M
Current liabilities	CAD 571,602
Current ratio	1.85
Net working capital	CAD 65,200
Quick ratio	1.54
Working capital	CAD 486,515
Working capital turnover	1.72

Metric

Value

Asset turnover

0.43

Current assets

CAD 1.1M

Current liabilities

CAD 571,602

Current ratio

1.85

Net working capital

CAD 65,200

Quick ratio

1.54

Working capital

CAD 486,515

Working capital turnover

1.72

Metric	Value
Buyback yield / dilution	-109.54%
Shareholder yield	-109.54%

Metric

Value

Buyback yield / dilution

-109.54%

Shareholder yield

-109.54%

Metric	Value
10Y price change	-99.39%
10Y return CAGR	-39.92%
10Y total return	-99.39%
150-day SMA	CAD 0.10
15Y price change	-99.83%
15Y return CAGR	-34.65%
15Y total return	-99.83%
1D price change	-7.14%
1M price change	-13.33%
1M total return	-13.33%
1W price change	-7.14%
1W total return	-7.14%
1Y price change	-35%
1Y return CAGR	-35.02%
1Y total return	-35%
20-day SMA	CAD 0.07
200-day SMA	CAD 0.09
20Y price change	-99.95%
20Y return CAGR	-31.97%
20Y total return	-99.95%
3M price change	-23.53%
3M total return	-23.53%
3Y price change	-74%
3Y return CAGR	-36.17%
3Y total return	-74%
50-day SMA	CAD 0.08
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.14
52-week high date	2025-12-30
52-week low	CAD 0.07
52-week low date	2026-10-29
5Y price change	-94.58%
5Y return CAGR	-44.19%
5Y total return	-94.58%
6M price change	-31.58%
6M total return	-31.58%
All-time high	CAD 1,228.85
All-time high date	2008-06-23
All-time low	CAD 0.03
All-time low date	2024-11-13
Average true range (ATR)	CAD 0.00
Average volume	90K
Beta (1Y)	-1.04
Beta (2Y)	0.43
Beta (5Y)	-0.78
Change from 52-week high	-51.85%
Change from 52-week low	0%
Change from all-time high	-99.99%
Change from all-time low	116.67%
Change from open	0%
Day's gap	-7.14%
Dollar volume	CAD 12,399
High price	CAD 0.07
Low price	CAD 0.07
Monthly RSI	39.3
Open price	CAD 0.07
Previous close	CAD 0.07
Price vs 150-day SMA	-33.2%
Price vs 20-day SMA	-11.32%
Price vs 200-day SMA	-29.19%
Price vs 50-day SMA	-23.08%
Relative volume	2.12
RSI	37.42
Sharpe ratio	0.78
Sharpe ratio (3Y)	0.67
Sharpe ratio (5Y)	0.6
Sortino ratio	1.28
Sortino ratio (3Y)	1.16
Sortino ratio (5Y)	1.04
Volume	190.8K
Weekly RSI	37.55
YTD price change	-48%
YTD total return	-48%

Metric

Value

10Y price change

-99.39%

10Y return CAGR

-39.92%

10Y total return

-99.39%

150-day SMA

CAD 0.10

15Y price change

-99.83%

15Y return CAGR

-34.65%

15Y total return

-99.83%

1D price change

-7.14%

1M price change

-13.33%

1M total return

-13.33%

1W price change

-7.14%

1W total return

-7.14%

1Y price change

-35%

1Y return CAGR

-35.02%

1Y total return

-35%

20-day SMA

CAD 0.07

200-day SMA

CAD 0.09

20Y price change

-99.95%

20Y return CAGR

-31.97%

20Y total return

-99.95%

3M price change

-23.53%

3M total return

-23.53%

3Y price change

-74%

3Y return CAGR

-36.17%

3Y total return

-74%

50-day SMA

CAD 0.08

50-day SMA vs 200-day SMA

50under200

52-week high

CAD 0.14

52-week high date

2025-12-30

52-week low

CAD 0.07

52-week low date

2026-10-29

5Y price change

-94.58%

5Y return CAGR

-44.19%

5Y total return

-94.58%

6M price change

-31.58%

6M total return

-31.58%

All-time high

CAD 1,228.85

All-time high date

2008-06-23

All-time low

CAD 0.03

All-time low date

2024-11-13

Average true range (ATR)

CAD 0.00

Average volume

90K

Beta (1Y)

-1.04

Beta (2Y)

0.43

Beta (5Y)

-0.78

Change from 52-week high

-51.85%

Change from 52-week low

Change from all-time high

-99.99%

Change from all-time low

116.67%

Change from open

Day's gap

-7.14%

Dollar volume

CAD 12,399

High price

CAD 0.07

Low price

CAD 0.07

Monthly RSI

39.3

Open price

CAD 0.07

Previous close

CAD 0.07

Price vs 150-day SMA

-33.2%

Price vs 20-day SMA

-11.32%

Price vs 200-day SMA

-29.19%

Price vs 50-day SMA

-23.08%

Relative volume

2.12

RSI

37.42

Sharpe ratio

0.78

Sharpe ratio (3Y)

0.67

Sharpe ratio (5Y)

0.6

Sortino ratio

1.28

Sortino ratio (3Y)

1.16

Sortino ratio (5Y)

1.04

Volume

190.8K

Weekly RSI

37.55

YTD price change

-48%

YTD total return

-48%

Metric	Value
Float	57.2M
Shares change (QoQ)	7.49%
Shares change (YoY)	109.54%
Shares held by insiders	8.44%
Shares held by institutions	0.72%
Shares outstanding	62.5M

Metric

Value

Float

57.2M

Shares change (QoQ)

7.49%

Shares change (YoY)

109.54%

Shares held by insiders

8.44%

Shares held by institutions

0.72%

Shares outstanding

62.5M

CSE/HEAL (CSE/HEAL)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/HEAL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/HEAL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/HEAL

Frequently asked questions